ERBB2 and breast carcinoma: Recent years have also seen the emergence of studies that applied scRNAseq to unravel complexity of breast cancer [122,123], including the immune environment of breast tumors [124,125], and response to Herceptin therapy that targets EGFR2 (Her2) [126].